Changzhou Qianhong Biopharma Co Ltd (002550) — Financial Flexibility Index
Changzhou Qianhong Biopharma Co Ltd (002550) has a Financial Flexibility Index of 0.67x as of September 2025. Free cash flow of CN¥171.92 Million (operating CF CN¥156.34 Million minus capex CN¥15.58 Million) represents 1% of total liabilities (CN¥255.86 Million). Also explore net asset growth rate of Changzhou Qianhong Biopharma Co Ltd to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Changzhou Qianhong Biopharma Co Ltd Financial Flexibility Index (2007–2025)
Historical Financial Flexibility Index trend for Changzhou Qianhong Biopharma Co Ltd across 19 annual periods. Check 002550 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Changzhou Qianhong Biopharma Co Ltd (2007–2025)
Year-by-year free cash flow to debt coverage for Changzhou Qianhong Biopharma Co Ltd. For the full company profile including market capitalisation, see market cap of Changzhou Qianhong Biopharma Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.57x | CN¥502.97 Million | CN¥361.36 Million | CN¥320.64 Million | ▼ -18.7% |
| 2024 | 1.93x | CN¥605.35 Million | CN¥514.71 Million | CN¥313.87 Million | ▼ -11.1% |
| 2023 | 2.17x | CN¥633.66 Million | CN¥533.33 Million | CN¥292.17 Million | ▲ +166574.0% |
| 2022 | 0.00x | CN¥-485.32K | CN¥-71.47 Million | CN¥372.53 Million | ▼ -100.3% |
| 2021 | 0.50x | CN¥193.94 Million | CN¥103.56 Million | CN¥390.24 Million | ▼ -49.4% |
| 2020 | 0.98x | CN¥379.81 Million | CN¥317.28 Million | CN¥386.35 Million | ▲ +125.6% |
| 2019 | 0.44x | CN¥262.23 Million | CN¥161.55 Million | CN¥601.65 Million | ▲ +116.3% |
| 2018 | 0.20x | CN¥128.98 Million | CN¥25.45 Million | CN¥640.11 Million | ▼ -32.3% |
| 2017 | 0.30x | CN¥176.15 Million | CN¥88.52 Million | CN¥591.41 Million | ▼ -49.6% |
| 2016 | 0.59x | CN¥359.95 Million | CN¥221.01 Million | CN¥609.33 Million | ▼ -36.6% |
| 2015 | 0.93x | CN¥502.28 Million | CN¥286.50 Million | CN¥538.67 Million | ▼ -51.5% |
| 2014 | 1.92x | CN¥342.54 Million | CN¥252.01 Million | CN¥178.06 Million | ▼ -36.0% |
| 2013 | 3.01x | CN¥288.06 Million | CN¥160.47 Million | CN¥95.77 Million | ▼ -33.3% |
| 2012 | 4.51x | CN¥264.02 Million | CN¥199.82 Million | CN¥58.54 Million | ▲ +126.8% |
| 2011 | 1.99x | CN¥173.13 Million | CN¥146.82 Million | CN¥87.07 Million | ▲ +47.1% |
| 2010 | 1.35x | CN¥182.15 Million | CN¥171.51 Million | CN¥134.75 Million | ▲ +1706.1% |
| 2009 | 0.07x | CN¥21.72 Million | CN¥8.35 Million | CN¥290.19 Million | ▼ -78.9% |
| 2008 | 0.36x | CN¥61.76 Million | CN¥54.36 Million | CN¥173.75 Million | ▼ -36.3% |
| 2007 | 0.56x | CN¥42.96 Million | CN¥35.99 Million | CN¥76.95 Million | — |